The Firm recently represented the underwriters, led by Barclays Capital Inc., BofA Securities, Inc. and J.P. Morgan Securities LLC, in connection with the public offering by CVS Health Corporation (“CVS Health”) of $1 billion of 2.125% Senior Notes due 2031. The offering closed August 18, 2021.
In addition, the Firm represented Barclays, Goldman Sachs and Wells Fargo Securities, LLC as dealer managers, in connection with a debt tender offer by CVS Health with respect to $2.05 billion of a tranche of Senior Notes due 2028.
CVS Health is the nation’s premier health innovation company. CVS Health has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 108 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 34 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan.
The Simpson Thacher team for the transactions included Roxane Reardon, Adriana Estor-Restrepo and Bethany Wong (Capital Markets); Nancy Mehlman, Jonathan Cantor and Kris Liu (Tax); Jennifer Neilsson (Benefits); Michael R. Isby (Environmental); Melanie Jolson (Intellectual Property); and Jennie Getsin (FINRA and Blue Sky).